These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 31887773

  • 1. A Review on the Update of Combined Hepatocellular Cholangiocarcinoma.
    Komuta M, Yeh MM.
    Semin Liver Dis; 2020 May; 40(2):124-130. PubMed ID: 31887773
    [Abstract] [Full Text] [Related]

  • 2. Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?
    Sasaki M, Sato Y, Nakanuma Y.
    Histopathology; 2022 Apr; 80(5):859-868. PubMed ID: 35076959
    [Abstract] [Full Text] [Related]

  • 3. Combined hepatocellular-cholangiocarcinoma: An update.
    Beaufrère A, Calderaro J, Paradis V.
    J Hepatol; 2021 May; 74(5):1212-1224. PubMed ID: 33545267
    [Abstract] [Full Text] [Related]

  • 4. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
    Zhou YM, Yang JM, Wang B, Xu F, Tong Y, Li DQ.
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):656-9. PubMed ID: 18086637
    [Abstract] [Full Text] [Related]

  • 5. Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.
    Kim TH, Kim H, Joo I, Lee JM.
    Korean J Radiol; 2020 Oct; 21(10):1115-1125. PubMed ID: 32729276
    [Abstract] [Full Text] [Related]

  • 6. Combined hepatocellular-cholangiocarcinoma and its mimickers: Diagnostic pitfalls in surgical pathology.
    Laohawetwanit T, Lerttanatum N, Wanpiyarat N, Manasilp N, Chaiparnich S.
    Ann Diagn Pathol; 2021 Aug; 53():151770. PubMed ID: 34147845
    [Abstract] [Full Text] [Related]

  • 7. cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.
    Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, Gouw A, Kagen A, Klimstra D, Komuta M, Kondo F, Miksad R, Nakano M, Nakanuma Y, Ng I, Paradis V, Nyun Park Y, Quaglia A, Roncalli M, Roskams T, Sakamoto M, Saxena R, Sempoux C, Sirlin C, Stueck A, Thung S, Tsui WMS, Wang XW, Wee A, Yano H, Yeh M, Zen Y, Zucman-Rossi J, Theise N.
    Hepatology; 2018 Jul; 68(1):113-126. PubMed ID: 29360137
    [Abstract] [Full Text] [Related]

  • 8. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.
    Yen CC, Yen CJ, Shan YS, Lin YJ, Liu IT, Huang HY, Yeh MM, Chan SH, Tsai HW.
    Histopathology; 2021 Oct; 79(4):556-572. PubMed ID: 33837585
    [Abstract] [Full Text] [Related]

  • 9. [Combined hepatocellular-cholangiocarcinoma].
    Jeen YM, Jin SY.
    Korean J Hepatol; 2007 Dec; 13(4):571-5. PubMed ID: 18159156
    [No Abstract] [Full Text] [Related]

  • 10. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Wang X, Wang W, Ma X, Lu X, Li S, Zeng M, Xu K, Yang C.
    Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM.
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [Abstract] [Full Text] [Related]

  • 13. Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases.
    Dusenbery D.
    Acta Cytol; 1997 Sep; 41(3):903-9. PubMed ID: 9167724
    [Abstract] [Full Text] [Related]

  • 14. Clinical, diagnostic, and pathologic features and surgical outcomes of combined hepatocellular-cholangiocarcinoma in dogs: 14 cases (2009-2021).
    Terai K, Ishigaki K, Kagawa Y, Okada K, Yoshida O, Sakurai N, Heishima T, Asano K.
    J Am Vet Med Assoc; 2022 Apr 27; 260(13):1668-1674. PubMed ID: 35482569
    [Abstract] [Full Text] [Related]

  • 15. [Radiologic staging of liver and pancreatic malignancies].
    Schima W, Ba-Ssalamah A.
    Radiologe; 1999 Jul 27; 39(7):568-77. PubMed ID: 10472085
    [Abstract] [Full Text] [Related]

  • 16. Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy.
    Nguyen CT, Caruso S, Maille P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brochériou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault JC, Allaire M, Mulé S, Zucman-Rossi J, Pawlotsky JM, Tournigand C, Lafdil F, Paradis V, Calderaro J.
    Clin Cancer Res; 2022 Feb 01; 28(3):540-551. PubMed ID: 34785581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma.
    Li Y, He D, Lu ZJ, Gu XF, Liu XY, Chen M, Tu YX, Zhou Y, Owen G, Zhang X, Jiang D.
    BMC Cancer; 2024 Oct 07; 24(1):1232. PubMed ID: 39375615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.